ISRCTN15245786进行中（未招募）1 期
Phase 1 trial HMR code: 23-001 The full scientific title will be published within 30 months after the end of the trial
Medherant Limited0 个研究点目标入组 24 人开始时间: 2023年8月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
排除标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-011Healthy volunteersISRCTN17328380Asceneuron (Switzerland)16
进行中（未招募）
1 期
Phase 1 trial HMR code: 22-017Healthy volunteersISRCTN51803225eurocrine Biosciences (United States)134
进行中（未招募）
1 期
Phase I trial HMR code: 23-007The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN10047421Gedeon Richter (Hungary)176
进行中（未招募）
1 期
Phase I trial; HMR code: 24-003Healthy volunteersISRCTN16055614Sling Therapeutics, Inc.20
进行中（未招募）
1 期
Phase I trial HMR code: 23-006ISRCTN23220202Gedeon Richter (Hungary)168